Retrospective investigation of cutaneous squamous cell carcinoma on the lip treated with peplomycin administered through a superficial temporal artery

Taku Fujimura, Kazuhiro Takahashi, Yumi Kambayashi, Sadanori Furudate, Takanori Hidaka, Aya Kakizaki, Akiko Watabe, Takahiro Haga, Akira Hashimoto, Setsuya Aiba

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Background: Continuous intra-arterial (IA) administration of peplomycin (PEP) through a tumor-feeding artery is one of the most effective treatments for cutaneous squamous cell carcinoma (cSCC) in cosmetic areas. Patients and Methods: In order to determine the effective and safe dose of PEP and the curative rate of IA-PEP, we retrospectively investigated a case series of 24 patients with cSCC on the lips who were treated with IA-PEP. Results: IA-PEP reduced the tumor mass in all 24 cases (100%). A complete response occurred in 17 patients (70.8%), and a partial response occurred in seven (29.2%). Moreover, 17 patients (70.8%) were cured, three patients developed cervical lymph node metastasis (12.5%), and four developed local recurrence (16.7%). Three out of the 24 patients developed interstitial pneumonia (12.5%). Conclusion: Low-dose IA-PEP administered through a superficial temporal artery was a highly effective treatment that achieved a curative response for 70.8% of patients with cSCC on the lips.

Original languageEnglish
Pages (from-to)1885-1889
Number of pages5
JournalAnticancer research
Volume37
Issue number4
DOIs
Publication statusPublished - 2017 Apr

Keywords

  • Continuous intra-arterial administration
  • Curative response
  • Cutaneous SCC on the lip
  • Interstitial pneumonia
  • Peplomycin

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Retrospective investigation of cutaneous squamous cell carcinoma on the lip treated with peplomycin administered through a superficial temporal artery'. Together they form a unique fingerprint.

Cite this